Patents Represented by Attorney Laura Ginkel
  • Patent number: 7855284
    Abstract: This invention relates to compounds, compositions, and methods useful for modulating checkpoint kinase (e.g., checkpoint kinase-1 or CHK-1) gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of checkpoint kinase gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of checkpoint kinase genes.
    Type: Grant
    Filed: December 17, 2009
    Date of Patent: December 21, 2010
    Assignee: Sirna Therapeutics, Inc.
    Inventors: James McSwiggen, Leonid Beigelman